New treatments for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) enhance patient care with gene therapies and new mechanisms of action on the horizon, explained Casey Koch, PharmD, from Select Health.
Casey Koch, PharmD
Advertisement
Casey Koch, PharmD, is a clinical pharmacy coordinator at Select Health.
Articles by Casey Koch, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
5 Notable FDA Approvals From the First Half of 2026
3
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
4
JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain
5